JALDA's Interview with Dr. Farshid Sadatsharifi

Authors

  • Bahram Behin Department of English, Facalty of Literature and Humanities, Azarbaijan Shahid Madani University, Tabriz, Iran
Abstract:

Farshid Sadatsharifi has been visiting scholar at the Institute of Islamic Studies in McGill University, Montreal, Canada since 2016. He received his PhD and MA in Persian Language and Literature from Shiraz University, Iran. He also completed his post-doc fellowship in Interdisciplinary Approaches to Literature at the same university. Dr. Sadatsharifi is the co-founder and director of Samaak Institution, the center for Persian Language and Literature in applied approach. He is the affiliated researcher of Hafez Studies Center, and a permanent member of Iranian Society of Persian Humor (ISPH). Dr. Sadatsharifi has spent ten years celebrating literary theories, the meaning of life, existentialism, and other subjects related to studying and teaching Persian Language and Literature in a multidisciplinary and applied approach. He hopes to have the chance to establish “applied literature” as a well-recognized part of literary studies. He believes that an applied approach is unavoidable for any form of art, humanities and literature nowadays. In pursuit of JALDA’s fundamental goal of spotlighting the nature of applied literature, the journal’s editor-in-chief, Dr. Bahram Behin, had a short conversation with Dr. Sadatsharifi.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

An interview with Dr

Professor of Medicine at the Mayo College of Medicine in Rochester, MN. He has been a consultant in the Division of Pulmonary, Critical Care and Sleep Medicine since 1988 and after receiving all of his training at Mayo, he obtained board certification in all of these subspecialties. He is now president of NAMDRC, Vice-Chair of the ACCP Home Care Network, and a delegate to the ACCP Sleep Institu...

full text

Interview with Dr. Hunter

A monoclonal antibody, FBT3, was raised against Tn positive erythrocytes and, using immuno-histochemistry, fresh and fixed tissues from patients with cancer were studied to detect any expression of a Tn-like epitope. Expression was found in neoplastic cells, usually both in cytoplasm and on cell membranes, from 104 of 147 cases of carcinoma and 1 of 13 cases of lymphoma, but rarely in adjacent,...

full text

Interview with Dr

Hyperbaric oxygen therapy involves inhaling 100% oxygen at greater than one atmosphere absolute (ATA) in a pressurized chamber. The air we breathe at sea level is defined as 1 ATA. Many of the clinical uses of hyperbaric oxygen therapy (HBOT) have been at pressures above 1.5 ATA. However, recently, some researchers have been using lower pressures of hyperbaric oxygen therapy with good results i...

full text

Interview with Prof. Dr. Murat Tuzcu

1. First of all, allow me to express my gratitude to you, Prof. Murat Tuzcu, for accepting this interview that will be published in Anatolian Journal of Cardiologythe official Journal of Turkish Society of Cardiology. You are undoubtedly a very well-known doctor in Turkey, and your biography is easily accessible elsewhere. However, aside from the “surgical” encyclopedic information, I would lik...

full text

Interview with Dr. Nicola Luigi Bragazzi.

Dr. Nicola Luigi Bragazzi is currently resident in Public Health at the National University of Genoa, Faculty of Medicine and Surgery, Italy. His research covers different areas, including: i) psychosocial processes and patient-related outcomes, such as quality of life and health locus of control in chronic illness with a particular emphasis on chronic kidney diseases and multiple sclerosis, ii...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 7  issue 1

pages  3- 6

publication date 2019-03-01

By following a journal you will be notified via email when a new issue of this journal is published.

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023